FLIP is essential for oncogenic KRAS-driven lung cancer
Claudia Hamilton, Shaun Sharkey, Hajrah A. Khawaja…·Daniel B. Longley
This study identifies FLIP as a critical survival factor in KRAS-mutant lung cancers, revealing a KRAS-ERK-FLIP axis that protects against apoptosis and suggests FLIP as a therapeutic target.